Parnell Pharmaceuticals Holdings Ltd. announced that it had appointed U.S. based Phyllis Gardner, MD, and David L. Greenwood to its Board of Directors, effective immediately. Dr. Gardner has over 35 years of experience in academia, medicine and the healthcare industry. Mr. Greenwood brings substantial expertise in financing pharmaceutical and biotechnology companies.

In conjunction with their appointments, Australian based Directors Andrew Want and Peter Molloy have resigned their Board positions. In conjunction with the appointment of two U.S. Independent Directors the two serving Australian-based Independent Directors, Andrew Want and Peter Molloy, have resigned their positions as Directors effective immediately. Dr. Gardner will serve as Chair of the Compensation Committee and as a Member of the Audit Committee and Nominating Committee.

Mr. Greenwood will serve as Chair of the Audit Committee and as a Member of the Compensation Committee and Nominating Committee.